SENTCELL LTD
Company number 12021050 · Active · London WC1E 6JF
SENTCELL LTD is an active private limited company (company number 12021050) incorporated on 29 May 2019, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 April 2025, showing net assets of £4.49m, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 8% on the prior period (£4.85m).
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
Key dates
- Incorporated
- 29 May 2019
- Next accounts due
- 30 January 2027 — in 100 days
- Confirmation statement due
- 12 June 2027 — in 233 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 30 April 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2025 | £4.49m | — | — | £9,502 | — | — | 0 |
| 30 April 2024 | £4.85m | — | — | £0 | — | — | 0 |
- Current ratio
- 135.96 — comfortable
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Firmoscan score: 76/100 (grade B)
- +10 Positive net assets — Net assets £4,488,832 at 2025-04-30
- +8 Comfortable liquidity — Current ratio 135.96
- +8 Established — Incorporated 2019-05-29 (7 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Dr. Alessio Lanna — owns 25–50% of shares; holds 75–100% of voting rights; can appoint or remove directors · since 29 May 2019
- Mr. Brendan Francis Blumer — owns 25–50% of shares · since 3 November 2025
- Mr. Jacopo Moretti — has significant influence or control · since 19 December 2025
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in London
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- MODERNA BIOTECH UK LIMITED — London, inc. May 2019
- ANIMA BIOTECH UK LIMITED — London, inc. May 2019
- NEWSUMMIT BIOPHARMA UK LIMITED — London, inc. May 2019
- MYRICX PHARMA LIMITED — London, inc. Jul 2019
- ALGAR HOLDING LIMITED — London, inc. Jul 2019
- BOOBYBIOME LTD — London, inc. Jul 2019
All companies incorporated on 29 May 2019 · in May 2019.
Reminders for SENTCELL LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.